TA Associates is preparing to sell Gong Cha at an eye‑catching valuation of about $2 billion, a sevenfold increase on the roughly $288 million it paid for a majority stake in 2019. If the deal proceeds at that price, TA would crystallise roughly $1.7 billion in gains after seven years, a rare headline‑grabbing return in the consumer sector.
Gong Cha began in Kaohsiung as a modest shop selling ‘‘tribute tea’’—a name that connoted quality. The brand expanded through East Asia and overseas in the 2000s, but its international breakout came after an Australian financier, Martin Berry, bought franchise rights and pursued aggressive franchising in Korea, using a simple tactic: open next to Starbucks and capture footfall from customers looking for something different.
Franchising fuelled rapid scale. Within a few years Gong Cha grew from a single Korean outlet to hundreds, even briefly approaching a thousand stores at its height. Capital soon followed: a Korean private equity firm bought the local operation, then engineered a reverse takeover of the Taiwanese parent, and finally TA Associates acquired global majority control in 2019 and relocated the headquarters to London, recasting Gong Cha as a hybrid global brand.
But Gong Cha’s China story diverted from that success. An overly permissive regional licensing model and weak trademark enforcement left the brand vulnerable to dozens of imitators. Faced with ‘‘liar‑brand’’ competitors, Gong Cha repeatedly rebranded portions of its China business and lost coherence in the consumer mindshare; its mainland store count has fallen sharply and its Shanghai operating company was wound up last year.
TA’s decision to shop the brand is primarily a fund‑cycle move. Private equity firms typically plan exits five to seven years after investment; with limited partners pressing for returns and the firm signalling a pullback from new consumer bets, monetising Gong Cha while valuations are rich is logical. The numbers are attractive: the brand reported about $600 million in systemwide sales in 2024 and $190 million in group revenue, which implies roughly a 10.5x revenue multiple at a $2 billion price.
The proposed sale is emblematic of larger themes in beverages and consumer private equity. Ready‑to‑drink and freshly prepared beverage formats combine high frequency, relatively low price and repeat purchase behaviour—attributes that make them resilient to cycles. Investors are rewarding scale, international distribution and franchising models that can be standardised; that is why assets such as Gong Cha, Blue Bottle’s China arm, and minority stakes in Starbucks China have attracted major deals recently.
Yet the growth story contains real execution and reputational risks. Ambitious expansion targets—Gong Cha has publicly set sights on a 10,000‑store global footprint by 2032—depend on disciplined franchisee selection, tight supply‑chain controls and trademark enforcement. The China experience is a cautionary tale: rapid licensing without centralised IP governance can erode brand equity and local revenues even as overseas franchising prospers.
For buyers, the calculus is straightforward: acquire a high‑frequency consumer brand with international reach and a playbook for compressing unit economics, then scale distribution and margins. For sellers, the outcome underscores private equity’s lifecycle logic and the premium the market places on repeatable, globalisable consumer businesses. For incumbent operators and policy makers, the Gong Cha saga highlights the trade‑offs between rapid franchising and the need for robust intellectual property and quality controls in international brand building.